BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19736213)

  • 1. Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis.
    Ergelen M; Uyarel H; Osmonov D; Ayhan E; Akkaya E; Soylu O; Orhan AL; Sayar N; Bozbay M; Turer A; Yildirim E; Yekeler I
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):33-41. PubMed ID: 19736213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
    Sibbing D; Morath T; Braun S; Stegherr J; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
    Thromb Haemost; 2010 Jan; 103(1):151-9. PubMed ID: 20062919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cardiovascular mortality in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention.
    Ergelen M; Gorgulu S; Uyarel H; Norgaz T; Ayhan E; Akkaya E; Soylu O; Ugur M; Tezel T
    Coron Artery Dis; 2010 Jun; 21(4):207-11. PubMed ID: 20354440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease.
    Migliorini A; Valenti R; Marcucci R; Parodi G; Giuliani G; Buonamici P; Cerisano G; Carrabba N; Gensini GF; Abbate R; Antoniucci D
    Circulation; 2009 Dec; 120(22):2214-21. PubMed ID: 19917884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
    Perez G; Rodriguez-Granillo AM; Mieres J; Llaurado C; Rubilar B; Risau G; Fernandez-Pereira C; Rodriguez AE
    J Invasive Cardiol; 2009 Aug; 21(8):378-82. PubMed ID: 19652248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal coronary blood flow after primary percutaneous coronary intervention for acute myocardial infarction: incidence, a simple risk score, and prognosis.
    Uyarel H; Ayhan E; Cicek G; Isik T; Ugur M; Bozbay M; Yildirim E; Ergelen M; Eren M
    Coron Artery Dis; 2012 Mar; 23(2):98-104. PubMed ID: 22318130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.
    Halkin A; Singh M; Nikolsky E; Grines CL; Tcheng JE; Garcia E; Cox DA; Turco M; Stuckey TD; Na Y; Lansky AJ; Gersh BJ; O'Neill WW; Mehran R; Stone GW
    J Am Coll Cardiol; 2005 May; 45(9):1397-405. PubMed ID: 15862409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of primary balloon angioplasty with bailout stenting strategy to primary coronary stenting strategy in the treatment of patients with ST-segment elevation myocardial infarction (STEMI).
    Tajstra M; Gasior M; Lekston A; Wilczek K; Hawranek M; Gierlotka M; Słonka G; Zebik T; Poloński L
    Kardiol Pol; 2007 Nov; 65(11):1277-84; discussion 1285-6. PubMed ID: 18058578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal relation between Clopidogrel cessation and stent thrombosis after drug-eluting stent implantation.
    Roy P; Bonello L; Torguson R; Okabe T; Pinto Slottow TL; Steinberg DH; Kaneshige K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Mar; 103(6):801-5. PubMed ID: 19268735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent thrombosis: a poor man's disease?
    Danenberg HD; Marincheva G; Varshitzki B; Nassar H; Lotan C
    Isr Med Assoc J; 2009 Sep; 11(9):529-32. PubMed ID: 19960845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a nationally representative managed-care population.
    Wiederkehr D; Ogbonnaya A; Casciano R; Makenbaeva D; Mozaffari E; Corbelli J
    Curr Med Res Opin; 2009 Sep; 25(9):2327-34. PubMed ID: 19635046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
    Lasala JM; Cox DA; Dobies D; Baran K; Bachinsky WB; Rogers EW; Breall JA; Lewis DH; Song A; Starzyk RM; Mascioli SR; Dawkins KD; Baim DS;
    Circ Cardiovasc Interv; 2009 Aug; 2(4):285-93. PubMed ID: 20031730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
    Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
    Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet reactivity in patients with subacute stent thrombosis compared with non-stent-related acute myocardial infarction.
    Lev EI; Alviar CL; Arikan ME; Dave BP; Granada JF; DeLao T; Tellez A; Maresh K; Kleiman NS
    Am Heart J; 2007 Jan; 153(1):41.e1-6. PubMed ID: 17174635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome.
    Beinart R; Abu Sham'a R; Segev A; Hod H; Guetta V; Shechter M; Boyko V; Behar S; Matetzky S
    Am Heart J; 2010 Jan; 159(1):118-24. PubMed ID: 20102877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
    Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
    Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.